TipRanks
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291)
:2291
Hong Kong Market
2291
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2291 full AI Analyst Report?

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (2291) Ratios

1 Followers

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H Ratios

HK:2291's free cash flow for Q2 2026 was ¥0.82. For the 2026 fiscal year, HK:2291's free cash flow was decreased by ¥ and operating cash flow was ¥0.52. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.54 23.54 16.79 23.89 20.92
Quick Ratio
 6.14 21.71 15.76 22.32 20.02
Cash Ratio
 5.16 19.06 13.33 20.46 14.86
Solvency Ratio
 1.00 4.48 2.88 2.80 -0.08
Operating Cash Flow Ratio
 0.87 3.64 2.64 2.77 1.03
Short-Term Operating Cash Flow Coverage
 257.16 234.56 0.00 0.00 0.00
Net Current Asset Value
¥ 1.33B¥ 1.37B¥ 1.33B¥ 1.36B¥ 1.26B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.12 1.03 1.04 1.03 1.04
Debt Service Coverage Ratio
 239.15 241.56 1.50K 820.77 0.74
Interest Coverage Ratio
 1.78K 2.37K 1.74K 777.85 -0.09
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 0.07
Net Debt to EBITDA
 -4.83 -3.95 -3.90 -6.39 -50.04
Profitability Margins
Gross Profit Margin
82.04%84.66%89.90%88.62%88.70%
EBIT Margin
43.28%48.64%60.69%53.24%1.59%
EBITDA Margin
50.72%55.42%61.08%58.06%7.59%
Operating Profit Margin
44.71%52.38%60.67%48.69%-0.70%
Pretax Profit Margin
46.35%52.37%60.66%53.17%-6.07%
Net Profit Margin
40.12%45.41%52.06%46.50%-8.00%
Continuous Operations Profit Margin
40.12%45.41%52.06%46.50%-8.00%
Net Income Per EBT
86.56%86.71%85.83%87.44%131.81%
EBT Per EBIT
103.65%99.97%99.98%109.21%870.92%
Return on Assets (ROA)
9.01%11.42%11.79%7.63%-1.09%
Return on Equity (ROE)
10.01%11.76%12.30%7.86%-1.14%
Return on Capital Employed (ROCE)
11.25%13.56%14.32%8.23%-0.10%
Return on Invested Capital (ROIC)
9.73%11.75%12.29%7.19%-0.10%
Return on Tangible Assets
11.35%14.61%13.76%8.14%-1.27%
Earnings Yield
5.42%4.79%4.33%1.77%-0.24%
Efficiency Ratios
Receivables Turnover
 3.50 4.54 6.53 9.57 8.09
Payables Turnover
 4.76 4.55 1.52 1.96 2.28
Inventory Turnover
 0.94 0.73 0.55 0.40 0.49
Fixed Asset Turnover
 4.35 4.40 3.85 2.99 2.54
Asset Turnover
 0.22 0.25 0.23 0.16 0.14
Working Capital Turnover Ratio
 0.37 0.39 0.35 0.25 0.37
Cash Conversion Cycle
 415.01 501.34 484.03 765.44 633.85
Days of Sales Outstanding
 104.26 80.34 55.90 38.12 45.12
Days of Inventory Outstanding
 387.41 501.14 668.78 913.11 748.65
Days of Payables Outstanding
 76.65 80.14 240.65 185.78 159.92
Operating Cycle
 491.66 581.48 724.68 951.23 793.77
Cash Flow Ratios
Operating Cash Flow Per Share
 0.60 0.64 0.64 0.47 0.20
Free Cash Flow Per Share
 0.45 0.42 0.40 0.19 -0.05
CapEx Per Share
 0.15 0.22 0.25 0.28 0.25
Free Cash Flow to Operating Cash Flow
 0.75 0.65 0.62 0.41 -0.27
Dividend Paid and CapEx Coverage Ratio
 4.01 0.76 0.79 1.68 0.79
Capital Expenditure Coverage Ratio
 4.01 2.89 2.60 1.68 0.79
Operating Cash Flow Coverage Ratio
 149.27 128.85 146.95 67.32 19.65
Operating Cash Flow to Sales Ratio
 0.41 0.42 0.47 0.50 0.26
Free Cash Flow Yield
4.19%2.89%2.42%0.78%-0.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.25 20.93 23.10 56.40 -418.24
Price-to-Sales (P/S) Ratio
 7.41 9.49 12.03 26.22 33.46
Price-to-Book (P/B) Ratio
 1.86 2.46 2.84 4.44 4.75
Price-to-Free Cash Flow (P/FCF) Ratio
 23.84 34.62 41.40 128.03 -464.78
Price-to-Operating Cash Flow Ratio
 17.90 22.65 25.50 52.03 126.45
Price-to-Earnings Growth (PEG) Ratio
 -0.65 -7.43 0.38 -0.07 3.17
Price-to-Fair Value
 1.86 2.46 2.84 4.44 4.75
Enterprise Value Multiple
 9.77 13.17 15.79 38.78 390.54
Enterprise Value
 2.50B 3.85B 4.55B 7.34B 7.35B
EV to EBITDA
 9.77 13.17 15.79 38.78 390.54
EV to Sales
 4.96 7.30 9.65 22.51 29.66
EV to Free Cash Flow
 15.95 26.64 33.19 109.91 -411.99
EV to Operating Cash Flow
 11.98 17.43 20.45 44.66 112.09
Tangible Book Value Per Share
 4.44 4.55 4.90 5.19 4.55
Shareholders’ Equity Per Share
 5.78 5.88 5.76 5.56 5.33
Tax and Other Ratios
Effective Tax Rate
 0.13 0.13 0.14 0.13 -0.32
Revenue Per Share
 1.45 1.52 1.36 0.94 0.76
Net Income Per Share
 0.58 0.69 0.71 0.44 -0.06
Tax Burden
 0.87 0.87 0.86 0.87 1.32
Interest Burden
 1.07 1.08 1.00 1.00 -3.82
Research & Development to Revenue
 0.10 0.11 0.12 0.19 0.22
SG&A to Revenue
 0.29 0.11 0.10 0.05 0.22
Stock-Based Compensation to Revenue
 0.00 0.00 0.02 0.06 0.08
Income Quality
 1.03 0.95 0.91 0.95 -4.36
Currency in CNY